Stephen Tindal, Director, Scientific Affairs, is based at Catalent’s Somerset, NJ, R&D facility and has nearly 30 years of experience in softgel formulation. He has wide expertise in commercializing many Rx, Gx, OTC and VMS products. His current role sees him supporting customers in applying softgel technologies to overcome specific API challenges. Mr Tindal holds a BSc in Chemistry and Analytical Science from Loughborough University, UK, and is a member of the Catalent Applied Drug Delivery Institute.